Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study (Q33495893)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study
scientific article

    Statements

    Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study (English)
    Quan Dong Nguyen
    Syed Mahmood Shah
    Jeffery S Heier
    Jennifer Lim
    Prema Abraham
    Peter A Campochiaro
    READ-2 Study Group
    2175-81.e1

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit